期刊
STATISTICS IN MEDICINE
卷 28, 期 5, 页码 721-738出版社
WILEY
DOI: 10.1002/sim.3511
关键词
meta-analysis; effect measures; arcsine transformation; rare events; zero event trials
类别
资金
- Evidence-Based Medicine Center of Excellence
- Pfizer, Inc.
- JRC
- Deutsche Forschungsgemeinschaft [FOR 534 Schw 821/2-2]
- National Science Foundation [0634013]
- Direct For Education and Human Resources
- Division Of Research On Learning [0634013] Funding Source: National Science Foundation
For clinical trials with binary endpoints there are a variety of effect measures, for example risk difference, risk ratio and odds ratio (OR). The choice of metric is not always straightforward and should reflect the clinical question. Additional issues arise if the event of interest is rare. In systematic reviews, trials with zero events in both arms are encountered and often excluded from the meta-analysis. The arcsine difference (AS) is a measure which is rarely considered in the medical literature. It appears to have considerable promise, because it handles zeros naturally, and its asymptotic variance does [lot depend on the event probability. This paper investigates the pros and cons of using the AS as a measure of intervention effect. We give a pictorial representation of its meaning and explore its properties in relation to other measures. Based on analytical calculation of the variance of the arcsine transformation, a more conservative variance estimate for the rare event setting is proposed. Motivated by a published meta-analysis in cardiac surgery, we examine the statistical properties of the various metrics in the rare event setting. We find the variance estimate of the AS to be more stable than that of the log-OR, even if events are rare. However, parameter estimation is biased if the groups are markedly unbalanced. Though, from a theoretical viewpoint, the AS is a natural choice, its practical use is likely to continue to be limited by its less direct interpretation. Copyright (C) 2008 John Wiley & Sons, Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据